Form 483

The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer Institute Form 483, 2018-08-30

FDA issued a Form 483 to The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer Institute on 2018-08-30 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer Institute · Salt Lake City, United States · Issued August 30, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Aug 2018
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Zachary A Bogorad, Scott J Lewis, Binh T Nguyen, Margaret E Walsh

30 Aug 2018
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Zachary A Bogorad, Scott J Lewis, Binh T Nguyen, Margaret E Walsh

30 Aug 2018
21 CFR 212.20(d)

Determination need for investigation

Cited by Zachary A Bogorad, Scott J Lewis, Binh T Nguyen, Margaret E Walsh

30 Aug 2018
21 CFR 212.60(d)

Supplies adequately controlled

Cited by Zachary A Bogorad, Scott J Lewis, Binh T Nguyen, Margaret E Walsh

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 212.20(d)Cited across public-safe Form 483 observations1x
21 CFR 212.60(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere